NO20085124L - 2-n-(-5-[[4-(2-(methyl-2-pyridinylamino)ethoxy]phenly]methyl]-2,4-thaizolidinedione)butanedioic acid, methods of preparation and compositions whit rosiglitazone - Google Patents

2-n-(-5-[[4-(2-(methyl-2-pyridinylamino)ethoxy]phenly]methyl]-2,4-thaizolidinedione)butanedioic acid, methods of preparation and compositions whit rosiglitazone

Info

Publication number
NO20085124L
NO20085124L NO20085124A NO20085124A NO20085124L NO 20085124 L NO20085124 L NO 20085124L NO 20085124 A NO20085124 A NO 20085124A NO 20085124 A NO20085124 A NO 20085124A NO 20085124 L NO20085124 L NO 20085124L
Authority
NO
Norway
Prior art keywords
methyl
methods
rosiglitazone
thaizolidinedione
phenly
Prior art date
Application number
NO20085124A
Other languages
English (en)
Inventor
Minutza Leibovici
Yehudit Dolitzky
Yoseph Avezov
Dina Spivak
Ben-Zion Solomon
Original Assignee
Teva Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teva Pharma filed Critical Teva Pharma
Publication of NO20085124L publication Critical patent/NO20085124L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

Beskrevet er en isolert forbindelse med formelen (I) sammen med fremgangsmåter for å detektere den og for å minimalisere den i forbedrede farmasøytiske sammensetninger av rosiglitazon maleat.
NO20085124A 2006-05-09 2008-12-09 2-n-(-5-[[4-(2-(methyl-2-pyridinylamino)ethoxy]phenly]methyl]-2,4-thaizolidinedione)butanedioic acid, methods of preparation and compositions whit rosiglitazone NO20085124L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2006/017994 WO2007130064A1 (en) 2006-05-09 2006-05-09 2-n-(5-[[4-(2-(methyl-2-pyridinylamino) ethoxy] phenyl]methyl]-2,4-thiazolidinedione) butanedioic acid, methods of preparation and compositions with rosiglitazone maleate

Publications (1)

Publication Number Publication Date
NO20085124L true NO20085124L (no) 2009-02-04

Family

ID=38668055

Family Applications (2)

Application Number Title Priority Date Filing Date
NO20085124A NO20085124L (no) 2006-05-09 2008-12-09 2-n-(-5-[[4-(2-(methyl-2-pyridinylamino)ethoxy]phenly]methyl]-2,4-thaizolidinedione)butanedioic acid, methods of preparation and compositions whit rosiglitazone
NO20092362A NO20092362L (no) 2006-05-09 2009-06-19 2-N-(5-[{4-(2-(metyl-2-pyridinylamino) etoksy] fenyl]metyl}2,4-tiazolidinedion) butanedisyre, fremgangsmater for fremstilling og sammensetninger med rosiglitazon maleat

Family Applications After (1)

Application Number Title Priority Date Filing Date
NO20092362A NO20092362L (no) 2006-05-09 2009-06-19 2-N-(5-[{4-(2-(metyl-2-pyridinylamino) etoksy] fenyl]metyl}2,4-tiazolidinedion) butanedisyre, fremgangsmater for fremstilling og sammensetninger med rosiglitazon maleat

Country Status (8)

Country Link
JP (1) JP2009536643A (no)
CN (1) CN101426789A (no)
BR (1) BRPI0621551A2 (no)
CA (1) CA2647829A1 (no)
IL (2) IL188175A0 (no)
MX (1) MX2008014298A (no)
NO (2) NO20085124L (no)
WO (1) WO2007130064A1 (no)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010013141A2 (en) * 2008-08-01 2010-02-04 Actavis Group Ptc Ehf Substantially pure rosiglitazone hydrogen sulfate
CN102863436B (zh) * 2012-06-19 2018-02-09 重庆医科大学 噻唑烷二酮类衍生物及其制备和用途

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5741803A (en) * 1992-09-05 1998-04-21 Smithkline Beecham Plc Substituted thiazolidinedionle derivatives

Also Published As

Publication number Publication date
MX2008014298A (es) 2008-11-26
CA2647829A1 (en) 2007-11-15
NO20092362L (no) 2009-02-04
IL199822A0 (en) 2011-07-31
WO2007130064A1 (en) 2007-11-15
WO2007130064A8 (en) 2008-11-13
BRPI0621551A2 (pt) 2016-08-16
CN101426789A (zh) 2009-05-06
JP2009536643A (ja) 2009-10-15
IL188175A0 (en) 2008-03-20

Similar Documents

Publication Publication Date Title
TW200637550A (en) Thiazole-4-carboxamide derivatives as mGluR5 antagonists
CL2008002142A1 (es) Compuestos derivados de 2-amino-6-({[2-(4-clorofenil)-1,3-tiazol-4-il]metil}tio)-4-[4-(2-hidroxietoxi) fenil] piridin-3,5-dicarbonitrilo; procedimiento de preparacion; composicion farmaceutica y uso en enfermedades cardiovasculares.
CO6160231A2 (es) Compuestos de isoindolina 5-substituidos
NZ589962A (en) Inhibitors of stearoyl-CoA desaturase and uses thereof
JP2006512357A5 (no)
ATE476431T1 (de) Piperidin- und azetidinderivate als glyt1- inhibitoren
WO2008046758A3 (en) Imidazolone and imidazolidinone derivatives as 11b-hsd1 inhibitors for diabetes
WO2007130075A8 (en) Aminothiazole derivatives as human stearoyl-coa desaturase inhibitors
EA201000486A1 (ru) Ингибитор белка, активирующего 5-липоксигеназу (flap)
DE602005023015D1 (de) Indolderivate als viruzide
EA200800727A1 (ru) Введение ингибиторов дипептидилпептидазы
WO2008021927A3 (en) Hepatitis c virus inhibitors
TW200700416A (en) 'n-(2-chloro-6-methylphenyl)-2-[[6-[4-(2-hydroxyethyl)-1-piperazinyl]-2-methyl-4-pyrimidinyl]amino]-5-thiazolecarboxamides metabolites
NO20085121L (no) Benzimidazolderivater, deres fremstillingsmate, deres anvendelse som FXR-agonister og farmasoytiske blandinger inneholdende samme
NO20091409L (no) Pyridin-3-yl-derivater som immunmodulerende midler
TR201908590T4 (tr) Nitrokatekol türevlerini içeren farmasötik formülasyonlar ve bunların üretimine yönelik yöntemler.
EA200701680A1 (ru) Лекарственная форма для перорального введения, содержащая розиглитазон
EA201071053A1 (ru) Кристаллическое производное бензимидазола
WO2007106879A3 (en) Process for preparing n-(2-chloro-6-methylphenyl)-2-[[6-[4-(2-hydroxyethyl)-1-piperazinyl]-2-methyl-4-pyrimidinyl]amino]-5-thiazolecarboxamide and related metabolites thereof
MX2009006636A (es) Nuevos intermediarios y procesos utiles en la rpeparacion de {2-[1-(3,5-bis-trifluorometil-bencil)-5-piridin-4-il-1h-[1,2,3]tr iazol-4-il]-piridin-3-il}-(2-clorofenil)-metanona.
PL2021002T3 (pl) Kompozycja farmaceutyczna zawierająca medoksomil olmesartanu
NO20085124L (no) 2-n-(-5-[[4-(2-(methyl-2-pyridinylamino)ethoxy]phenly]methyl]-2,4-thaizolidinedione)butanedioic acid, methods of preparation and compositions whit rosiglitazone
EA200870224A1 (ru) Бензо[f]изоиндол-2-илфенильные производные уксусной кислоты в качестве агонистов рецепторов ep
Ölgen et al. Antimicrobial and antiviral screening of novel indole carboxamide and propanamide derivatives
EA200900725A1 (ru) Полиморфы гидробромида 5-{2-[4-(1,2-бензоизотиазол-3-ил)-1-пиперазинил]этил}-6-хлор-1,3-дигидро-2н-индол-2-она и способы их получения

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application